Risk Of Developing Liver Cancer After HCV Treatment

Saturday, March 9, 2013

AASLD oral presentations from "Hepatitis C Treatment in Special Populations"

AASLD 2012-63rd Annual Meeting

AASLD is pleased to announce the availability of the newly webcasted presentations from the AASLD Hepatitis C Treatment in Special Populations Conference on LiverLearning®: The Official eLearning Portal of AASLD.

AASLD - Liver Learning
If you haven't yet explored the "Liver Learning" section available @ the AASLD website you're missing out on meeting webcasts, video podcasts, abstracts and more. The presentations can be viewed on your computer, Android Smartphones or Tablets.

To access presentations through "TALKS on the GO", please visit www.talksonthego.com or download it through the Apple App Store or Google Play store for Android Smartphones and Tablets by searching for: "Talks on the Go" (Please note you must include the quotation marks)
To access oral presentations from "Hepatitis C Treatment in Special Populations":
1) Go to: liverlearning.aasld.org
2) Register or Click "Sign In" on the top right corner
3) Enter your username and password
4) Click on the "Events" tab and start browsing!

*Free registration required

Newly Webcasted Presentations
     
Session 1: Current State of the Art Therapy by Gentoype
 Stuart C. Gordon
Genotype 1, Naive

(Podcast available)
 Eugene R. Schiff
Genotype 1, Treatment-Experienced

(PowerPoint shared by the speaker; Podcast available)
 Alessandra Mangia Genotype 2/3: Naïve/Treatment Experienced

(PowerPoint shared by the speaker; Podcast available)
 Norah Terrault
Genotype 4-6: Naïve/Treatment Experienced

(Podcast available)
 Panel Discussion
Panel Discussion

(Podcast available)
Session 2: Special Populations as Designated by FDA
 Maureen M. Jonas
Pediatrics

(Podcast available)
 Norbert Brau
HIV/HCV Coinfection

(PowerPoint shared by the speaker; Podcast available)
 Geoffrey M. Dusheiko
Bleeding Disorders

(PowerPoint shared by the speaker; Podcast available)
 Marina Berenguer
Liver Transplant Recipients

(Podcast available)
 Fred Poordad
IDUs, Including Methadone/Partial Agonists: Counterpoint

(Podcast available)
 Diana Sylvestre
IDUs, Including Methadone/Partial Agonists: Point

(Podcast available)
 Panel Discussion
Panel Discussion

(Podcast available)
Session 3: Treating in the Face of Comorbidities
 Stephen Harrison
Coexistent Liver Diseases (NAFLD, HBV, Autoimmune)

(PowerPoint shared by the speaker; Podcast available)
 Michael W. Fried
Renal Insufficiency/Hemodialysis

(Podcast available)
 Glenn Treisman
Psychiatric/Alcohol

(PowerPoint shared by the speaker; Podcast available)
Session 4: Treating Patients with Hepatitis C to Prevent Related Diseases
 Marina Berenguer
Cryoglobulinemia - MPGN, Neuropathy, Vasculitis, Arthritis

(PowerPoint shared by the speaker; Podcast available)
 Jordan Feld
Lymphoma and Other Lymphorproliferative Malignancies

(PowerPoint shared by the speaker; Podcast available)
 Francesco Negro
Diabetes

(PowerPoint shared by the speaker; Podcast available)
 Hashem B. El-Serag
HCC/ Cholangiocarcinoma

(PowerPoint shared by the speaker; Podcast available)
 Panel Discussion
Panel Discussion

(Podcast available)
Session 5: Potpourri of Special Groups
 Jordan Feld
Acute Hepatitis

(PowerPoint shared by the speaker; Podcast available)
 Michael R. Lucey
Prisoners/Incarcerated

(Podcast available)
 Geoffrey M. Dusheiko
Elderly: Counterpoint

(PowerPoint shared by the speaker; Podcast available)
 Eugene R. Schiff
Elderly: Point

(PowerPoint shared by the speaker; Podcast available)
 W Ray Kim
Towards Cost-effective Care in Special Populations

(PowerPoint shared by the speaker; Podcast available)
 Panel Discussion
Panel Discussion

(Podcast available)
Session 6: Towards the Elimination of Special Populations
 Michael W. Fried
What's New with IFN-Based Therapies

(Podcast available)
 Fred Poordad
What's New with DAA Combo Therapies

(Podcast available)
 Jeffrey Murray
Expanded Access to Special Populations: Panel Discussion

(PowerPoint shared by the speaker; Podcast available)
 Stuart C. Gordon Introduction - Expanded Access to Special Populations: Panel Discussion

(Podcast available)
 Nisha K. Gupta
Expanded Access to Special Populations: Panel Discussion

(Podcast available)

No comments:

Post a Comment